IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 317.15M | 338.41M | 278.45M | 248.19M | 274.61M |
| Total Depreciation and Amortization | 40.56M | 41.05M | 37.68M | 38.72M | 36.63M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.42M | 24.64M | 39.87M | 51.87M | 111.05M |
| Change in Net Operating Assets | 77.59M | -56.94M | -89.75M | 16.98M | -19.95M |
| Cash from Operations | 449.72M | 347.16M | 266.25M | 355.76M | 402.34M |
| Capital Expenditure | -28.93M | -24.65M | -31.98M | -29.43M | -31.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -223.43M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.26M | -850.00K | -1.56M | 1.30M | -13.76M |
| Cash from Investing | -248.10M | -25.50M | -33.54M | -28.13M | -44.87M |
| Total Debt Issued | -45.00M | -11.00M | 132.00M | 193.00M | -124.00M |
| Total Debt Repaid | -75.00M | -- | -- | -325.00M | 0.00 |
| Issuance of Common Stock | 31.48M | 32.91M | 18.16M | 17.87M | 50.97M |
| Repurchase of Common Stock | -112.32M | -347.10M | -361.59M | -237.83M | -240.28M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -3.74M | -- |
| Cash from Financing | -200.85M | -325.19M | -211.43M | -355.70M | -313.31M |
| Foreign Exchange rate Adjustments | -167.00K | -72.00K | -816.00K | -24.00K | -587.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 603.00K | -3.60M | 20.46M | -28.10M | 43.57M |